Browsing Other ICR Research by author "Kranc, Kamil"
Now showing items 1-2 of 2
-
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia.
Lawson, H; Holt-Martyn, JP; Dembitz, V; Kabayama, Y; Wang, LM; et al. (NATURE PORTFOLIO, 2024-06-01)Acute myeloid leukemia (AML) is a largely incurable disease, for which new treatments are urgently needed. While leukemogenesis occurs in the hypoxic bone marrow, the therapeutic tractability of the hypoxia-inducible factor ... -
A time- and single-cell-resolved model of murine bone marrow hematopoiesis
Kucinski, I; Campos, J; Barile, M; Severi, F; Bohin, N; et al. (CELL PRESS, 2024-02-01)